 |
FEDERAL CIRCUIT DENIES REHEARING EN BANC ON COLLATERAL ESTOPPEL OF IPRS * *
Kroy IP Holdings, LLC v. Groupon, Inc., 23-1359
|
August 01, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT’S CLAIM CONSTRUCTION WAS NOT SUPPORTED BY COMMON SPECIFICATION *
FMC Corp. v. Sharda USA, LLC, 24-2335
|
August 01, 2025 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT ABUSED DISCRETION IN EXCLUDING AUTHENTICATING TESTIMONY*
Jiaxing Super Lighting Elec. Appliance, Co., Ltd. v. CH Lighting Tech. Co., Ltd., 23-1715
|
July 28, 2025 |
IPO Federal Circuit Summaries |
|
APPEAL OF LICENSING ROYALTY AWARD DID NOT NECESSARILY RAISE ISSUE OF PATENT LAW * *
Acorda Therapeutics, Inc. v. Alkermes PLC, 23-23-74
|
July 25, 2025 |
IPO Federal Circuit Summaries |
![]() |
IPOwners Quarterly™ 7/23/2025
|
July 23, 2025 |
IPOwners Quarterly |
|
USPTO INCORRECTLY DETERMINED COMMERCIAL IMPRESSIONS OF MARKS *
Sunkist Growers, Inc. v. Intrastate Dists., Inc., 24-1212
|
July 23, 2025 |
IPO Federal Circuit Summaries |
|
USPTO CORRECTLY DECLINED TO APPLY INTERFERENCE ESTOPPEL TO INTER PARTES REVIEW * *
IGT v. Zynga Inc., 23-2262
|
July 22, 2025 |
IPO Federal Circuit Summaries |
|
PROSECUTION HISTORY ESTOPPEL PRECLUDES APPLICATION OF DOCTRINE OF EQUIVALENTS * *
Colibri Heart Valve LLC v. Medtronic Corevalve, LLC, 23-2153
|
July 18, 2025 |
IPO Federal Circuit Summaries |
|
DOCTRINE OF PROSECUTION DISCLAIMER APPLIES TO DESIGN PATENTS* *
Top Brand LLC v. Cozy Comfort Co. LLC, 24-2191
|
July 17, 2025 |
IPO Federal Circuit Summaries |
|
FINAL WRITTEN DECISION DOES NOT DETERMINE IF APPLICANT-ADMITTED PRIOR ART WAS USED AS A BASIS IN IPR PETITION* *
Shockwave Med., Inc. v. Cardiovascular Sys., Inc., 23-1864, 23-1940
|
July 14, 2025 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT REJECTS BLANKET RULE FOR PRESUMPTION OF OBVIOUSNESS*
Janssen Pharms., Inc. v. Teva Pharms. USA, Inc.
|
July 08, 2025 |
IPO Federal Circuit Summaries |
|
COURT DECLINES TO ENGAGE IN CLAIM CONSTRUCTION ON APPEAL OF SUMMARY JUDGMENT *
Engenera, Inc. v. Cisco Sys., Inc., 23-1428
|
July 07, 2025 |
IPO Federal Circuit Summaries |
![]() |
Atypical Claim Construction Was Supported by the Prosecution History* *
Eye Therapies LLC v. Slayback Pharm, LLC, 23-2173
|
June 30, 2025 |
|
|
FEDERAL CIRCUIT DOES NOT HAVE APPELLATE JURISDICTION OVER ITC SECTION 1337(H) DETERMINATIONS * *
Reaktek Semiconductor Corp. v. Int’l Trade Comm., 23-1187
|
June 18, 2025 |
IPO Federal Circuit Summaries |
|
USPTO APPLIED OVERLY STRICT STANDARD TO DETERMINE NEXUS TO LICENSES SUBMITTED AS OBJECTIVE INDICIA * *
Ancora Techs., Inc. v. Roku, Inc., 2023-1674, 2023-1701
|
June 16, 2025 |
IPO Federal Circuit Summaries |
|
VERDICT FORM VIOLATED DEFENDANT’S RIGHT TO A UNANIMOUS JURY* *
Optis Cellular Tech., LLC v. Apple Inc., 22-1904, 22-1925
|
June 16, 2025 |
IPO Federal Circuit Summaries |
 |
IPO Comments to CNIPA Regarding Draft Amendment to the Patent Examination Guidelines
|
June 15, 2025 |
Testimony and Comments |
|
MOBILE CHECK DEPOSIT SYSTEM WAS A PATENT INELIGIBLE ABSTRACT IDEA*
United Servs. Automobile Assoc. v. PNC Bank N.A., 23-1639, 23-1866, 25-1276, 25-1341
|
June 12, 2025 |
IPO Federal Circuit Summaries |
|
DECLARATORY JUDGMENT DENIED DUE TO LACK OF REASONABLE APPREHENSION OF INFRINGEMENT*
Mitek Sys., Inc. v. United Servs. Automobile Assoc., 23-1687
|
June 12, 2025 |
IPO Federal Circuit Summaries |
|
CRISPR-CAS SYSTEM ANTICIPATED BY SUFFICIENTLY ENABLING PRIOR ART * *
Agilent Techs., Inc. v. Synthego Corp., 23-2186, 23-2187
|
June 11, 2025 |
IPO Federal Circuit Summaries |
 |
Resolution Opposing “Skinny Labels, Big Savings Act” (S. 43)
|
June 10, 2025 |
Board Resolutions |
|
SIRIUS XM FAILED TO SHOW IT MATERIALLY RELIED ON MISLEADING CONDUCT IN EQUITABLE ESTOPPEL DEFENSE* *
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. v. Sirius XM Radio Inc., 23-2267
|
June 09, 2025 |
IPO Federal Circuit Summaries |
|
35 U.S.C. § 312(A)(2) DOES NOT CREATE AN INFORMATIONAL RIGHT * *
Dolby Labs. Licensing Corp. v. Unified Pats., LLC, 23-2110
|
June 05, 2025 |
IPO Federal Circuit Summaries |
|
ALNYLAM ACTED AS LEXICOGRAPHER THROUGH DEFINING TERM IN PATENT’S SPECIFICATION * *
Alnylam Pharms., Inc. v. Moderna, Inc., 23-2357
|
June 04, 2025 |
IPO Federal Circuit Summaries |
|
IPO’s Letter to the American Law Institute (ALI) Requesting Removal of Name from Copyright Restatement Project
|
June 02, 2025 |
Testimony and Comments |
|
USPTO IMPROPERLY ENGAGED IN CLAIM CONSTRUCTION DURING OBVIOUSNESS ANALYSIS* *
Sigray, Inc. v. Carl Zeiss Microscopy, Inc., 23-2211
|
May 23, 2025 |
IPO Federal Circuit Summaries |
|
LEXMARK FRAMEWORK APPLIES TO COMMERCIAL BASES OF OPPOSITION UNDER 15 U.S.C. § 1063*
Curtain v. United Trademark Holdings, Inc., 23-2140
|
May 22, 2025 |
IPO Federal Circuit Summaries |
|
DOCTRINE OF FOREIGN EQUIVALENTS WHERE APPELLANT FAILED TO SHOW MARK WAS UNLIKELY TO BE TRANSLATED BY CONSUMERS* *
In re Vetements Grp. AG, 23-2050, 23-2051
|
May 21, 2025 |
IPO Federal Circuit Summaries |
|
EXPERT TESTIMONY ON REASONABLE ROYALTY RATE WAS INADMISSIBLE UNDER FRE 702 AND DAUBERT* * *
Ecofactor, Inc. v. Google LLC, 23-1101
|
May 21, 2025 |
IPO Federal Circuit Summaries |
|
IPO’s Comments to China’s NMPA on the “Implementation Measures for the Protection of Drug Trial Data” and the “Working Procedures for the Protection of Drug Trial Data.”
|
May 18, 2025 |
Testimony and Comments |
|
USPTO FAILED TO CONSIDER ROUTINE SKILLS AND TECHNIQUES IN CONCEPTION ANALYSIS* *
Regents of U.C. v. Broad Inst., Inc., 22-1594, 22-1653
|
May 12, 2025 |
IPO Federal Circuit Summaries |
|
PRELIMINARY INJUNCTION WAS IMPROPER WHEN COMPETITIVE HEAD START WAS INEVITABLE* *
Incyte Corp. v. Sun Pharma. Indus., Ltd., 25-1162
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
PLANS TO DEVELOP DRUG WERE TOO SPECULATIVE TO CONFER STANDING*
Incyte Corp. v. Sun Pharma. Indus. Inc., 23-1300
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
USPTO MAY CONSIDER EVIDENCE AS OF THE TIME OF EXAMINATION IN DETERMINING REGISTRATION UNDER LANHAM ACT § 2(A)*
In re Foster, 23-1527
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
IPR ESTOPPEL DOES NOT APPLY TO EVIDENCE THE INVENTION WAS KNOWN OR USED BY OTHERS, ON SALE, OR IN PUBLIC USE* *
Ingenico Inc. v. IOENGINE LLC, 23-1367
|
May 07, 2025 |
IPO Federal Circuit Summaries |
|
FINTIV DIGITAL WALLET CLAIMED MEANS-PLUS-FUNCTION TERMS SUBJECT TO 35 U.S.C. § 112 ¶ 6 * *
Fintiv Inc. v. PayPal Holdings Inc., 23-2312
|
April 30, 2025 |
IPO Federal Circuit Summaries |
|
IPO Request to Testify and Hearing Statement re: World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge
|
April 29, 2025 |
Testimony and Comments |
|
FEDERAL CIRCUIT ADOPTS MILWAUKEE TEST FOR GENERICNESS * *
In re: PT Medisafe Techs., 23-1573
|
April 29, 2025 |
IPO Federal Circuit Summaries |
|
Resolution Stating That Trademark Licensors Have All Rights of Their Licensees
|
April 23, 2025 |
Board Resolutions |
|
USPTO INCORRECTLY INTERPRETED “IN COMBINATION” RULE UNDER 35 U.S.C. § 311(B) * *
Qualcomm Inc. v. Apple Inc., 23-1208, 23-1209
|
April 23, 2025 |
IPO Federal Circuit Summaries |
